𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors

✍ Scribed by Maria Möllemann; Marietta Wolter; Jörg Felsberg; V. Peter Collins; Guido Reifenberger

Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
556 KB
Volume
113
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Allelic losses on the chromosome arms 1p and 19q have been associated with favorable response to chemotherapy and good prognosis in anaplastic oligodendroglioma patients, but the molecular mechanisms responsible for this relationship are as yet unknown. The DNA repair enzyme O^6^‐methylguanine DNA methyltransferase (MGMT) may cause resistance to DNA‐alkylating drugs commonly used in the treatment of anaplastic oligodendrogliomas and other malignant gliomas. We report on the analysis of 52 oligodendroglial tumors for MGMT promoter methylation, as well as mRNA and protein expression. Using sequencing of sodium bisulfite‐modified DNA, we determined the methylation status of 25 CpG sites within the MGMT promoter. In 46 of 52 tumors (88%), we detected MGMT promoter hypermethylation as defined by methylation of more than 50% of the sequenced CpG sites. Real‐time reverse transcription‐PCR showed reduced MGMT mRNA levels relative to non‐neoplastic brain tissue in the majority of tumors with hypermethylation. Similarly, immunohistochemical analysis showed either no or only small fractions of MGMT positive tumor cells. MGMT promoter hypermethylation was significantly more frequent and the percentage of methylated CpG sites in the investigated MGMT promoter fragment was significantly higher in tumors with loss of heterozygosity on chromosome arms 1p and 19q as compared to tumors without allelic losses on these chromosomes arms. Taken together, our data suggest that MGMT hypermethylation and low or absent expression are frequent in oligodendroglial tumors and likely contribute to the chemosensitivity of these tumors.

📜 SIMILAR VOLUMES

Frequent promoter hypermethylation and t
Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma
✍ Martin Tepel; Peter Roerig; Marietta Wolter; David H. Gutmann; Arie Perry; Guido 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 571 KB

## Abstract The N‐myc downstream‐regulated gene 2 (__NDRG2__) at 14q11.2 has been reported to be downregulated in glioblastoma, and NDRG2 overexpression represses glioblastoma cell proliferation __in vitro__ (Deng et al., Int J Cancer 2003;106;342–7). To further address the role of __NDRG2__ as a c

Promoter hypermethylation of tumor-relat
Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia
✍ Alfa H.C. Bai; Joanna H.M. Tong; Ka-Fai To; Michael W.Y. Chan; Ellen P.S. Man; K 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 594 KB

## Abstract Gene promoter hypermethylation is increasingly recognized to play an important role in cancer development through silencing of gene transcription. This study determined the methylation profiles of primary colorectal cancers and adenomas to elucidate the role of epigenetic changes in dif

Promoter hypermethylation profile of tum
Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma
✍ Muthusamy Viswanathan; Nobuo Tsuchida; Govindaswamy Shanmugam 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 211 KB

## Abstract Aberrant promoter hypermethylation of tumor‐associated genes leading to their inactivation is a common event in many cancer types. Using a sensitive restriction‐multiplex PCR method, we studied the promoter hypermethylation profile of the __p16, p15, hMLH1, MGMT__ and __E‐cad__ genes in

Promoter hypermethylation of the EDNRB g
Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma
✍ Kwok-Wai Lo; Yuen-Shan Tsang; Joseph Kwong; Ka-Fai To; Peter M.L. Teo; Dolly P. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 590 KB

## Abstract To identify the epigenetic changes in nasopharyngeal carcinoma (NPC), we performed methylation‐sensitive restriction fingerprinting (MSRF) analysis on NPC cell lines and xenografts. A 190 bp sequence methylated in NPC tumors was isolated and showed high homology to the 5′ CpG island of

Frequent biallelic inactivation and tran
Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss
✍ Markus J. Riemenschneider; Julia Reifenberger; Guido Reifenberger 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 670 KB

## Abstract Deletion of the short arm of chromosome 1 is common in oligodendroglial tumors and has been identified as a powerful molecular marker for response to radio‐ and chemotherapy as well as favorable prognosis. Here, we investigated a series of 59 human primary gliomas for aberrations of the